Johnson & Johnson reported positive survival rates and treatment outcomes using the Impella device in high-risk percutaneous coronary intervention.

Zhitongcaijing · 2d ago
Johnson & Johnson reported positive survival rates and treatment outcomes using the Impella device in high-risk percutaneous coronary intervention.